Entero Healthcare Solutions
Entero Healthcare Solutions Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Entero Healthcare Solutions Limited, framed against the sector median so the premium or discount is obvious at a glance.
Entero Healthcare Solutions Limited trades at a P/E of 43.57× and P/B of 2.97×, against the Consumer Services sector median P/E of 33.96×.
Valuation
Profitability
Growth
Financial Health
Entero Healthcare Solutions Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Entero Healthcare Solutions Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Entero Healthcare Solutions Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Entero Healthcare Solutions Limited, switchable between annual and quarterly views, consolidated or standalone.
Entero Healthcare Solutions Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹50,62,86,73,790.1 Cr and reported EPS of ₹26.44.
| Period | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue from Operations | 3,922 | 5,096 | 6,591 |
| Other Income | 14 | 40 | 19 |
| Total Income | 3,937 | 5,135 | 6,610 |
| Cost of Goods Sold (COGS) | 3,570 | 4,609 | 5,911 |
| Gross Profit | 352 | 486 | 680 |
| +Operating Expenses | 240 | 315 | 414 |
| EBITDA | 112 | 172 | 266 |
| +Non-Operating Expenses | 91 | 72 | 90 |
| Profit Before Tax (PBT) | 36 | 139 | 179 |
| +Tax Expense | -4 | 31 | 33 |
| Total Profit for Period | 40 | 107 | 146 |
| Less: Non-controlling Interests | 1 | 13 | 31 |
| Net Profit (Owner's PAT) | 39 | 95 | 115 |
| Earnings Per Share (EPS) | 8.99 | 21.79 | 26.44 |
| Diluted Shares Outstanding (Nos.) | 4 | 4 | 4 |
| +Additional Disclosures | 7,472 | 9,619 | 12,364 |
| Sales Growth % | — | 29.92 | 29.35 |
| YoY Sales Growth % | — | 29.92 | 29.35 |
| Employee Cost % | 4 | 4 | 4 |
| Other Cost % | 2 | 2 | 3 |
| OPM % | 3 | 3 | 4 |
| Tax % | -12 | 23 | 19 |
| Profit Growth % | — | 142.45 | 21.33 |
| Gross Margin % | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 87 | 141 | 223 |
Entero Healthcare Solutions segment analysis: revenue and profit mix.
Disclosed business segments at Entero Healthcare Solutions with their share of revenue and profit, switchable between consolidated and standalone reporting.
Entero Healthcare Solutions discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Entero Healthcare Solutions Limited.
Our AI distills the core fundamental drivers supporting Entero Healthcare Solutions Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Entero Healthcare Solutions Limited's investment case rests on 6 positive markers and 7 flagged concerns drawn from the latest reported filings.
What you're getting.
Entero Healthcare demonstrates strong operational performance with a 28% increase in quarterly sales and a significant 38.4% surge in quarterly profits, indicating healthy market demand and efficient management.
The company maintains a substantial promoter holding of 52.4%, reflecting leadership's confidence. A low debt-to-equity ratio of 0.22 further strengthens its financial stability and reduces risk.
Quarterly net profit has shown a positive trend, growing from 4 Cr in Dec 2022 to 30 Cr in June 2025, showcasing consistent improvement in the company's bottom line over time.
Operating in the "Pharmacy Retail" industry, Entero is well-positioned to capitalize on the expanding healthcare market and increasing demand for pharmaceutical products and services in India.
With its robust quarterly sales growth of 28%, Entero has the potential to aggressively expand its market share within the fragmented pharmacy retail sector, leveraging its operational efficiency.
What can break it.
Despite profit growth, the Return on Capital Employed (ROCE) at 8.71% and Return on Equity (ROE) at 5.63% are relatively modest, suggesting potential for better capital utilization and efficiency improvements.
Entero's P/E ratio of 46.90 is high, indicating a premium valuation. The stock also shows recent volatility, trading near its 52-week low of 1044.90, which could concern investors.
Foreign Institutional Investors (FIIs) have reduced their stake from 23.82% in Sep 2024 to 14.68% in Sep 2025, which might signal a cautious outlook from institutional investors.
The pharmacy retail sector is highly competitive, with both organized and unorganized players. This intense competition could pressure Entero's margins and hinder its ability to sustain high growth rates.
The pharmaceutical industry is subject to strict and evolving regulations. Any adverse changes in drug pricing policies or distribution norms could significantly impact Entero's business model and profitability.
What would change my mind.
Trim if P/E re-rates above 57 (~1.7× the sector multiple of 34.0). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Entero Healthcare Solutions Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Entero Healthcare Solutions Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
Entero Healthcare Solutions Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Entero Healthcare Solutions Limited — derived from the live tape, not yesterday's close.
Entero Healthcare Solutions Limited last traded at ₹1,163.3 with an intraday range of ₹1,090–₹1,198 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1163.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1426.87 | +263.57 | +22.66% |
| R3 | 1318.87 | +155.57 | +13.37% |
| R2 | 1258.43 | +95.13 | +8.18% |
| R1 | 1210.87 | +47.57 | +4.09% |
| PIVOT | 1150.43 | -12.87 | -1.11% |
| CURRENT | 1163.30 | — | — |
| S1 | 886.87 | -276.43 | -23.76% |
| S2 | 994.87 | -168.43 | -14.48% |
| S3 | 1042.43 | -120.87 | -10.39% |
| S4 | 1102.87 | -60.43 | -5.19% |
ENTERO is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 1090 ~ 1129.5
Trading Above opening range, showing Bullishness
Entero Healthcare Solutions Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Entero Healthcare Solutions Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Entero Healthcare Solutions Limited stood at 17.2% of traded volume, against a 20-day average of 51.2%.
Entero Healthcare Solutions announcements: results, concalls, ratings, M&A.
Filings Entero Healthcare Solutions sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Entero Healthcare Solutions files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 121 documents below.
Disclosure under SEBI Takeover Regulations
Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Disclosure under SEBI Takeover Regulations
Prem Sethi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Analysts/Institutional Investor Meet/Con. Call Updates
Entero Healthcare Solutions Limited has informed the Exchange about Transcript
Copy of Newspaper Publication
Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication
Analysts/Institutional Investor Meet/Con. Call Updates
Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Entero Healthcare Solutions dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Entero Healthcare Solutions has declared, sequenced by announce and record date.
Entero Healthcare Solutions corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Entero Healthcare Solutions Limited: business, sector, key facts.
What Entero Healthcare Solutions Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Entero Healthcare Solutions Limited operates in the Pharmacy Retail industry under the Consumer Services sector, listed as NSE: ENTERO, BSE: 544122.
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited is a Mumbai-based Indian company established in 2018 that operates within the healthcare sector. Its core business revolves around the distribution and trading of a wide range of pharmaceutical and surgical products. This extensive portfolio caters to a diverse clientele, including retail pharmacies, hospitals, manufacturers of healthcare products, and healthcare clinics across India.
The company's distribution network encompasses several key product categories. A significant portion of its business involves medical devices, a market segment experiencing considerable growth in India. This includes a variety of products designed for both professional and home healthcare settings. Entero also distributes over-the-counter (OTC) medical products, offering readily accessible healthcare solutions to consumers.
Further diversifying its offerings, Entero distributes nutraceuticals, which are products intended to supplement dietary intake and improve overall health and well-being. This area taps into the rising consumer awareness and demand for health-conscious choices. The company also plays a role in the distribution of vaccines, contributing to crucial public health initiatives and disease prevention programs within the country.
In addition to its broader distribution activities, Entero offers specific medical devices directly to consumers. Examples of these products include nebulizers for respiratory treatments, digital thermometers for accurate temperature readings, blood pressure monitors for cardiovascular health monitoring, and adult diapers for incontinence care. This direct-to-consumer approach complements its wholesale distribution operations and solidifies its position in the healthcare market.
In summary, Entero Healthcare Solutions Limited's business model combines wholesale distribution to healthcare institutions and direct-to-consumer sales of select medical devices. Its diverse product portfolio, spanning pharmaceuticals, surgical supplies, medical devices, nutraceuticals, and vaccines, positions it as a significant player in the dynamic Indian healthcare market. The company’s relatively recent founding suggests a growth trajectory focused on expanding its market reach and product offerings within the Indian healthcare landscape.
Questions investors ask about Entero Healthcare Solutions Limited (ENTERO).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Entero Healthcare Solutions Limited (ENTERO)?
The current share price of Entero Healthcare Solutions Limited (ENTERO) is ₹1,163.3. Today, the stock has gained by ₹75.30 (6.92%), trading in a range of ₹1,090 to ₹1,198. The stock opened at ₹1,093.4 with a trading volume of 6,36,167 shares.
02Is Entero Healthcare Solutions Limited stock a good investment for long-term?
Entero Healthcare Solutions Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹50,62,86,73,790.1 crores, P/E ratio of 43.57, ROE of 8.28%, and ROCE of 8.71%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Entero Healthcare Solutions Limited stock?
The 52-week high price of Entero Healthcare Solutions Limited (ENTERO) is ₹1,390, while the 52-week low is ₹944. Currently trading at ₹1,163.3, the stock is 49.2% away from its 52-week low and 16.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Entero Healthcare Solutions Limited stock at the current price?
Whether to buy Entero Healthcare Solutions Limited stock at ₹1,163.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 43.57 and P/B ratio of 2.97. Today's performance shows a gain of 6.92%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Entero Healthcare Solutions Limited and when is the next dividend?
Entero Healthcare Solutions Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹1,163.3, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Entero Healthcare Solutions Limited?
Entero Healthcare Solutions Limited's key financial metrics include: P/E Ratio: 43.57, P/B Ratio: 2.97, ROE: 8.28%, ROCE: 8.71%, Dividend Yield: 0.00%, EPS: ₹26.44, Book Value: ₹388.26, and Debt-to-Equity: 0.39. The company's market cap stands at ₹50,62,86,73,790.1 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Entero Healthcare Solutions Limited stock performing today in the market?
Entero Healthcare Solutions Limited stock opened at ₹1,093.4 and is currently trading at ₹1,163.3, showing a gain of ₹75.30 (6.92%). The intraday high is ₹1,198 and low is ₹1,090. The trading volume stands at 6,36,167 shares, indicating moderate market participation today.
08What is the P/E ratio of Entero Healthcare Solutions Limited and what does it indicate?
Entero Healthcare Solutions Limited has a Price-to-Earnings (P/E) ratio of 43.57, which means investors are willing to pay ₹43.57 for every ₹1 of earnings. With an EPS of ₹26.44, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Entero Healthcare Solutions Limited (ENTERO) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aditya Birla Lifestyle Brands (ABLBL) Share PricePeer
- Advent Hotels International (ADVENTHTL) Share PricePeer
- Asian Hotels (West) (AHLWEST) Share PricePeer
- Apollo Sindoori Hotels (APOLSINHOT) Share PricePeer
- Blue Coast Hotels (BLUECOAST) Share PricePeer
- Top Gainers TodayScreener
- Other overvalued NSE stocksScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy